Galetta Steven L

Bennett Jeffrey L, Costello Fiona, Chen John J, Petzold Axel, Biousse Valérie, Newman Nancy J et al.

This review highlights that optic neuritis subtypes, like those linked to MS or MOGAD, have distinct prognoses. Early, accurate diagnosis guides tailored treatments, improving visual outcomes and preventing severe atrophy.

Walter Scott D, Ishikawa Hiroshi, Galetta Kristin M, Sakai Reiko E, Feller Daniel J, Henderson Sam B et al.

This study found that ganglion cell loss (GCL+IPL thinning) in MS patients, especially after optic neuritis, strongly correlates with worse visual function and quality of life, making it a key disease marker.

Ney Joshua J, Volpe Nicholas J, Liu Grant T, Balcer Laura J, Moster Mark L, Galetta Steven L

This study found functional visual loss is prevalent in IIH patients, often linked to psychiatric issues. Careful assessment is crucial before surgery.

Fisher Jennifer B, Jacobs Dina A, Markowitz Clyde E, Galetta Steven L, Volpe Nicholas J, Nano-Schiavi M Ligia et al.

This study found MS patients have thinner RNFL, even without optic neuritis, which correlates with worse low-contrast vision. This supports RNFL and low-contrast acuity as MS trial biomarkers.

Thorne Jennifer E, Volpe Nicholas J, Wulc Allan E, Galetta Steven L

This case highlights how sclerosing orbital inflammation can masquerade as tumors, emphasizing that definitive diagnosis often requires extensive pathology to prevent misdiagnosis and guide appropriate treatment.